Keros Therapeutics Inc (KROS)

Financing Cash Flow

-$3.32M

Quarterly · Period ending: · USD

KROS logo

KROS Financing Cash Flow

Latest reported-$3.32M
KROS Quarterly Cash from Financing ($0.00 → -$3.32M)
High-resolution chart · PNG

KROS financing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Keros Therapeutics Inc Financing Cash Flow — Quarterly (USD)
Period endingFinancing Cash Flow (USD)
-3,315,000
-2,316,000
-378,631,000
140,000
17,000
4,000
75,544,000
155,944,000
3,531,000
156,802,000
69,254,000
284,000
1,740,000
107,678,000
61,416,000
48,583,000
10,192,000
118,000
28,416,000
35,000
57,000
42,000
140,117,000
9,000
100,124,000
55,794,000
4,000
6,000
4,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.